Current partner codePEPTIDESDE
PeptideStat
Menu

Vendors

Compare pricesVendor directoryVendor reviewsDiscount codesLab tests & COAs

Research

ResearchDatabaseClinical trials

Tools

All calculatorsReconstitutionAccumulationUnit converterPeptide chemistry

Therapeutic-area index

LongevityPeptide Trials.

Explore peptide clinical trials tagged to the longevity condition group in the current local registry snapshot. Condition groups are PeptideStat search classifications layered over source-reported indications.

Studies
37
Recruiting
12
Completed
12
Results posted
6
Countries
16
Avg enrollment
140

Velocity

Longevity trials by start year

Study start year · indexed snapshot

6532020032003: 1 trials2004: 0 trials2005: 0 trials2006: 2 trials20072007: 2 trials2008: 0 trials2009: 0 trials2010: 3 trials20112011: 0 trials2012: 0 trials2013: 2 trials2014: 0 trials20152015: 1 trials2016: 1 trials2017: 0 trials2018: 2 trials20192019: 3 trials2020: 2 trials2021: 2 trials2022: 0 trials20232023: 2 trials2024: 5 trials2025: 6 trials20262026: 3 trials

Development

Trials by phase

Early Phase 12
Phase 14
Phase 211
Phase 30
Phase 45

Industry

Leading sponsors

Novartis2
Allon Therapeutics1
GlaxoSmithKline1

Therapeutic areas

Condition groups

Longevity37
Brain health7
Weight loss7
Inflammation1
Pain1
Type 2 diabetes1

Compound leaders

Most represented peptides.

01Degarelix402Exenatide403Nesiritide304Secretin305Ganirelix206Semaglutide207Teriparatide208Tesamorelin209Tirzepatide210Vasopressin211Albiglutide112Bivalirudin1

Study explorer

Search this collection.

37 matching studies